Cyclerion Therapeutics (CYCN) SEC Filings & 10K Form

$2.85
0.00 (0.00%)
(As of 05/17/2024 ET)

Recent Cyclerion Therapeutics SEC Filings

DateFilerForm TypeView
04/29/2024
3:18 PM
Cyclerion Therapeutics (Filer)
Form DEF 14A
04/29/2024
3:21 PM
Cyclerion Therapeutics (Filer)
Form DEFA14A
02/09/2024
4:06 PM
Artal International S.C.A. (Filed by)
Cyclerion Therapeutics (Subject)
Form SC 13G/A
02/09/2024
7:50 AM
Cyclerion Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/22/2024
2:44 PM
Cyclerion Therapeutics (Subject)
Slate Path Capital LP (Filed by)
Form SC 13G/A
12/04/2023
4:09 PM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/01/2023
7:01 AM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/24/2023
12:06 PM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2023
3:30 PM
Cyclerion Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/23/2023
3:58 PM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/05/2023
3:05 PM
Cyclerion Therapeutics (Subject)
TYNDALL CAPITAL PARTNERS L P (Filed by)
Form SC 13G
07/19/2023
4:27 PM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2023
3:12 PM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/27/2023
3:53 PM
Cyclerion Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/20/2023
3:55 PM
Cyclerion Therapeutics (Filer)
Form DEFM14A
06/09/2023
4:23 PM
Cyclerion Therapeutics (Filer)
Form PREM14A
05/23/2023
3:00 PM
Cyclerion Therapeutics (Subject)
Hecht Peter M (Filed by)
Form SC 13D/A
05/22/2023
7:43 PM
Cyclerion Therapeutics (Issuer)
Hecht Peter M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:CYCN) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners